NASDAQ: FNVTFinnovate Acquisition Corp Stock
$11.25+0.00 (+0%)
Updated Apr 18, 2024
FNVT Price
$11.25
Fair Value Price
N/A
Market Cap
$102.22M
52 Week Low
$10.43
52 Week High
$11.50
P/E
59.21x
P/B
-36.55x
P/S
N/A
PEG
0.29x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.49M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$787k
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
FNVT Overview
Finnovate Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets Israel-related companies focused on payments, fintech as a service, banking as a service, blockchain and crypto, and lending and credit line platforms. Finnovate Acquisition was incorporated in 2021 and is based in George Town, the Cayman Islands.
Zen Score
–
Industry Average (8)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FNVT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FNVT ($11.25) is trading below its intrinsic value of $14.62, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FNVT is poor value based on its earnings relative to its share price (59.21x), compared to the US market average (41.33x)
P/E vs Market Valuation
FNVT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more FNVT due diligence checks available for Premium users.
Be the first to know about important FNVT news, forecast changes, insider trades & much more!
FNVT News
Valuation
FNVT fair value
Fair Value of FNVT stock based on Discounted Cash Flow (DCF)
Price
$11.25
Fair Value
$11.14
Overvalued by
1.03%
FNVT ($11.25) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
FNVT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
59.21x
Industry
34.4x
Market
41.33x
FNVT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FNVT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
FNVT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-36.55x
Industry
-14.07x
FNVT price to earnings growth (PEG)
For valuing profitable companies with growth potential
FNVT is good value based... subscribe to Premium to read more.
PEG Value Valuation
FNVT's financial health
Profit margin
Revenue
$0.0
Net Income
$82.5k
Profit Margin
0%
FNVT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$51.2M
Liabilities
$2.8M
Debt to equity
-1.01
FNVT's short-term liabilities ($2.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FNVT's short-term assets ($37.43k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FNVT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FNVT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$543.3k
Investing
-$300.0k
Financing
$842.5k
FNVT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FNVT vs Shell Company Stocks
Finnovate Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.